NewLink Genetics Corporation: Diferență între versiuni
Admin (discuție | contribuții) (Pagină nouă: Pagina dedicata companiei NewLink Genetics Corporation listata cu simbolul US.NLNK ==Descriere companie== Lumos Pharma Inc (www.newlinkgenetics.com) is a clinical stage biopharmaceutical company focused on the development and commercialization of therapeutics for rare and neglected diseases. The company's therapeutic candidate is LUM-201, an oral growth hormone stimulating small molecule, is in late-stage clinical development for the treatment of Pediatric Growth Hormone Def...) |
(Nicio diferență)
|
Versiunea de la data 18 septembrie 2024 20:16
Pagina dedicata companiei NewLink Genetics Corporation listata cu simbolul US.NLNK
Descriere companie
Lumos Pharma Inc (www.newlinkgenetics.com) is a clinical stage biopharmaceutical company focused on the development and commercialization of therapeutics for rare and neglected diseases. The company's therapeutic candidate is LUM-201, an oral growth hormone stimulating small molecule, is in late-stage clinical development for the treatment of Pediatric Growth Hormone Deficiency (PGHD).
Grafic actiuni companie